Abstract
High-dose liquid antibiotics are uncommon in bone cement. We present a case series of patients in which up to 16 mL of liquid amikacin (250 mg mL - 1 ) was successfully incorporated into bone cement to treat periprosthetic joint infections. We did not observe adverse drug reactions definitively attributed to its use.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 147-150 |
| Number of pages | 4 |
| Journal | Journal of Bone and Joint Infection |
| Volume | 6 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2021 |
Bibliographical note
Copyright: © 2021 Don Bambino Geno Tai et al.PubMed: MeSH publication types
- Journal Article